€
160.85
Change
+1.45 +0.91%
Volume
Volume 2
Dec 1, 2023, 8:27 a.m.
Quotes are delayed by 20 min
Previous close
€ 159.40
€ 160.85
Change
+1.45 +0.91%
Day low
Day high
€160.30
€160.85

52 week low
52 week high
n/a
n/a

Market cap
N/A
Average volume
N/A
P/E ratio
N/A
Rev. per Employee
€286,891
EPS
N/A
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MRK
-
Merck posts higher profit and revenue as it lifts sales forecast
- Carlo Martuscelli
-
Merck KGaA expects deal to close in second half
- Ciara Linnane
-
Merck KGaA in definitive agreement to acquire Versum in deal with enterprise value of 5.8 bln euros
- Ciara Linnane
-
Merck KGaA expects deal to immediately boost earnings per share
- Ciara Linnane
-
Merck KGaA could receive up to about $4.2 bln in milestone payments as part of GlaxoSmithKline deal
- Tomi Kilgore
-
Merck KGaA to receive upfront payment of about $342.8 mln as part of GlaxoSmithKline collaboration
- Tomi Kilgore
-
GlaxoSmithKline, Merck KGaA to collaborate on cancer treatments
- Tomi Kilgore
-
Stock market ends with losses as tech and consumer staples skid
- Ryan Vlastelica
-
Watch for ‘violent selloff’ to thwart Saudis’ wish for $100 oil
- Barbara Kollmeyer
-
Pfizer shares down 0.9% premarket
- Ciara Linnane
-
Merck, Pfizer say late-stage trial of stomach cancer drug did not meet its main goals
- Ciara Linnane
-
Merck rises 2% after health business is put up for sale
- Sara Sjolin
-
Merck KGaA preparing strategic options for consumer health ops, shares up 2.9%
- Carla Mozee
- Loading more headlines...
Other News on MRK
-
Long Wait for Cancer Drug Trial Results
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Germany's Merck Posts Higher Profit
- The Wall Street Journal Interactive Edition
-
Merck KGaA Cuts Profit Forecast
- The Wall Street Journal Interactive Edition
-
Novartis Seen Gaining as Merck Scraps MS Drug
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Pills Offer Easier Way to Treat MS
- The Wall Street Journal Interactive Edition
-
Settlement Reached In MS Drug Case
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
GM Considers Its Paint Options
- The Wall Street Journal Interactive Edition
-
China Inflation Keeps Markets Tame
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Nissan Expects Full Production Within Weeks
- The Wall Street Journal Interactive Edition
-
Pigment Shortage Hits Auto Makers
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on MRK
No News currently available for MRK
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com